Use of oral contraceptives in the treatment of women with polycystic ovary syndrome

By Stovall Dale W   Menke Marie   Springel Edward   Jarvis Amber   Karjane Nicole  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 347-355

Informa Healthcare

Access to resources Recommend Favorite

Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone

By Cataldo N.A.   Abbasi F.   McLaughlin T.L.   Lamendola C.   Reaven G.M.  

Fertility and Sterility, Vol. 76, Iss. 5, 2001-11 ,pp. : 1057-1059

Elsevier

Access to resources Recommend Favorite

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

By Azziz R.   Ehrmann D.A.   Legro R.S.   Fereshetian A.G.   O'Keefe M.   Ghazzi M.N.   PCOS/Troglitazone Study Group  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 932-937

Elsevier

Access to resources Recommend Favorite

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess

By Moran C.   Reyna R.   Boots L.S.   Azziz R.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 126-131

Elsevier

Access to resources Recommend Favorite

Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes

By Villaseca P   Hormaza P   Cárdenas I   Oestreicher E   Arteaga E  

The European Journal of Contraception and Reproductive Health Care, Vol. 9, Iss. 3, 2004-09 ,pp. : 155-165

Informa Healthcare

Access to resources Recommend Favorite